National Institute of Mental Health; Notice of Meeting, 32559-32560 [2014-13026]
Download as PDF
Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices
accessible by webcast and conference
call.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute (NCI) Ad hoc Clinical Trials
Strategic Planning Subcommittee of the
NCI Clinical Trials and Translational
Research Advisory Committee (CTAC),
July 8, 2014, 2:00 p.m. to July 8, 2014,
3:00 p.m., National Cancer Institute
Shady Grove, Shady Grove, 9609
Medical Center Drive, 6West CCCT
Huddle Room, Rockville, MD, 20850
which was published in the Federal
Register on May 8, 2014, 79 FR 26441.
This notice is being amended to
change the meeting type to a webinar.
The meeting will be open to the public.
Pertinent information related to the
webinar is as follows:
Go to: https://cbiit.webex.com/cbiit/
j.php?MTID=m3d3b0b1886a6e7b32fb
f568ae44f6915
Meeting Password: ctac.
Meeting Number: 735 128 827.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Open Meeting.
Date: July 8, 2014.
Time: 9:00 a.m. to 5:00 p.m.* Eastern Time
* Approximate end time.
Agenda: To discuss committee business,
updates and issues related to ASD research
and services activities.
Place: National Institute of Mental Health,
The Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C and D,
Rockville, Maryland 20852.
Webcast Live: https://videocast.nih.gov/.
National Institute of Mental Health;
Notice of Meeting
Conference Call
Access: Dial: 888–946–7606, Access code:
9653752.
Cost: The meeting is free and open to the
public.
Registration: Pre-registration is
recommended to expedite check-in. Seating
in the meeting room is limited to room
capacity and on a first come, first served
basis. To register, please visit:
www.iacc.hhs.gov.
Deadlines: Notification of intent to present
oral comments: Monday, June 30, 2014 by
5:00 p.m. ET. Submission of written/
electronic statement for oral comments:
Tuesday, July 1, 2014 by 5:00 p.m. ET.
Submission of written comments: Tuesday,
July 1, 2014 by 5:00 p.m. ET.
Please note: The NIMH Office of Autism
Research Coordination (OARC) anticipates
that written public comments received by
5:00 p.m. ET, Tuesday, July 1, 2014 will be
presented to the Committee prior to the July
8th meeting for the Committee’s
consideration. Any written comments
received after the 5:00 p.m. EST, July 1, 2014
deadline through July 7, 2014 will be
provided to the Committee either before or
after the meeting, depending on the volume
of comments received and the time required
to process them in accordance with privacy
regulations and other applicable Federal
policies.
For IACC Public Comment guidelines,
please see: https://iacc.hhs.gov/publiccomment/index.shtml.
Access: White Flint Metro Station (Red
Line).
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda,
MD 20892–9669, Phone: 301–443–6040,
Email: IACCPublicInquiries@mail.nih.gov.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Autism
Coordinating Committee (IACC or
Committee) meeting.
The purpose of the IACC meeting is
to discuss committee business, agency
updates and issues related to autism
spectrum disorder (ASD) research and
services activities. The meeting will be
open to the public and will be
Public Comments
Any member of the public interested
in presenting oral comments to the
Committee must notify the Contact
Person listed on this notice by 5:00 p.m.
ET on Monday, June 30, 2014, with their
request to present oral comments at the
meeting. Interested individuals and
representatives of organizations must
submit a written/electronic copy of the
oral presentation/statement including a
brief description of the organization
Audio Connection
1. Provide your number when you
join the meeting to receive a call back.
Alternatively, you can call the following
number: Dial In Number: 1–240–276–
6338.
2. Follow the instructions that you
hear on the phone. Your Cisco Unified
MeetingPlace meeting ID: 730 501 868.
Dated: May 31, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13025 Filed 6–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
rmajette on DSK2TPTVN1PROD with NOTICES
National Institutes of Health
VerDate Mar<15>2010
14:59 Jun 04, 2014
Jkt 232001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
32559
represented by 5:00 p.m. ET on
Tuesday, July 1, 2014. Statements
submitted will become a part of the
public record. Only one representative
of an organization will be allowed to
present oral comments and
presentations will be limited to three to
five minutes per speaker, depending on
the number of speakers to be
accommodated within the allotted time.
Speakers will be assigned a time to
speak in the order of the date and time
when their request to speak is received,
along with the required submission of
the written/electronic statement by the
specified deadline.
In addition, any interested person
may submit written comments to the
IACC prior to the meeting by sending
the comments to the Contact Person
listed on this notice by 5:00 p.m. ET on
Tuesday, July 1, 2014. The comments
should include the name, address,
telephone number and when applicable,
the business or professional affiliation
of the interested person. NIMH
anticipates written public comments
received by 5:00 p.m. ET, Tuesday, July
1, 2014 will be presented to the
Committee prior to the meeting for the
Committee’s consideration. Any written
comments received after the 5:00 p.m.
EST, July 1, 2014 deadline through July
7, 2014 will be provided to the
Committee either before or after the
meeting, depending on the volume of
comments received and the time
required to process them in accordance
with privacy regulations and other
applicable Federal policies. All written
public comments and oral public
comment statements received by the
deadlines for both oral and written
public comments will be provided to
the IACC for their consideration and
will become part of the public record.
In the 2009 IACC Strategic Plan, the
IACC listed the ‘‘Spirit of Collaboration’’
as one of its core values, stating that,
‘‘We will treat others with respect, listen
to diverse views with open minds,
discuss submitted public comments,
and foster discussions where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
(OARC) ask that members of the public
who provide public comments or
participate in meetings of the IACC also
seek to treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
Remote Access
The meeting will be open to the
public through a conference call phone
E:\FR\FM\05JNN1.SGM
05JNN1
32560
Federal Register / Vol. 79, No. 108 / Thursday, June 5, 2014 / Notices
number and webcast live on the
Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an email to helpdeskiacc@
gmail.com or by phone at 415–652–
8023.
Individuals who participate in person
or by using these electronic services and
who need special assistance, such as
captioning of the conference call or
other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least 5
days prior to the meeting.
Security
In the interest of security, visitors will
be asked to show one form of
identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit upon entrance to
the Neuroscience Center. Also as a part
of security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
on a first come, first served basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
Information about the IACC is
available on the Web site: https://
www.iacc.hhs.gov.
Dated: May 30, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13026 Filed 6–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rmajette on DSK2TPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Mar<15>2010
14:59 Jun 04, 2014
Jkt 232001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Gene and Drug Delivery Systems
Study Section.
Date: June 12–13, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Baltimore Marriott Waterfront, 700
Aliceanna Street, Baltimore, MD 21202.
Contact Person: Amy L Rubinstein, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7844, Bethesda, MD 20892, 301–408–
9754, rubinsteinal@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Targets for Cancer Intervention.
Date: June 30, 2014.
Time: 7:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Careen K Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301)435–
3504, tothct@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pain and Chemosensory
Neuroscience.
Date: July 1–2, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–HG–
14–001: BD2K–LINCS-Perturbation Data
Coordination and Integration Center.
Date: July 2, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD.
Contact Person: James J Li, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5148, MSC 7849, Bethesda, MD
20892, 301–806–8065, lijames@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Review Group; Neurogenesis and Cell Fate
Study Section.
Date: July 2, 2014.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington Embassy Row,
2015 Massachusetts Ave. NW., Washington,
DC 20036.
Contact Person: Joanne T Fujii, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 30, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13027 Filed 6–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: 2015 National Survey on Drug
Use and Health (OMB No. 0930–0110)—
Revision
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
Federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
In order to continue producing
current data, SAMHSA’s Center for
Behavioral Health Statistics and Quality
(CBHSQ) must periodically update
aspects of the NSDUH to reflect the
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 79, Number 108 (Thursday, June 5, 2014)]
[Notices]
[Pages 32559-32560]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of an Interagency
Autism Coordinating Committee (IACC or Committee) meeting.
The purpose of the IACC meeting is to discuss committee business,
agency updates and issues related to autism spectrum disorder (ASD)
research and services activities. The meeting will be open to the
public and will be accessible by webcast and conference call.
Name of Committee: Interagency Autism Coordinating Committee
(IACC).
Type of meeting: Open Meeting.
Date: July 8, 2014.
Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end
time.
Agenda: To discuss committee business, updates and issues
related to ASD research and services activities.
Place: National Institute of Mental Health, The Neuroscience
Center, 6001 Executive Boulevard, Conference Rooms C and D,
Rockville, Maryland 20852.
Webcast Live: https://videocast.nih.gov/.
Conference Call
Access: Dial: 888-946-7606, Access code: 9653752.
Cost: The meeting is free and open to the public.
Registration: Pre-registration is recommended to expedite check-
in. Seating in the meeting room is limited to room capacity and on a
first come, first served basis. To register, please visit:
www.iacc.hhs.gov.
Deadlines: Notification of intent to present oral comments:
Monday, June 30, 2014 by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments: Tuesday, July 1, 2014 by
5:00 p.m. ET. Submission of written comments: Tuesday, July 1, 2014
by 5:00 p.m. ET.
Please note: The NIMH Office of Autism Research Coordination
(OARC) anticipates that written public comments received by 5:00
p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee
prior to the July 8th meeting for the Committee's consideration. Any
written comments received after the 5:00 p.m. EST, July 1, 2014
deadline through July 7, 2014 will be provided to the Committee
either before or after the meeting, depending on the volume of
comments received and the time required to process them in
accordance with privacy regulations and other applicable Federal
policies.
For IACC Public Comment guidelines, please see: https://iacc.hhs.gov/public-comment/index.shtml.
Access: White Flint Metro Station (Red Line).
Contact Person: Ms. Lina Perez, Office of Autism Research
Coordination, National Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone:
301-443-6040, Email: IACCPublicInquiries@mail.nih.gov.
Public Comments
Any member of the public interested in presenting oral comments to
the Committee must notify the Contact Person listed on this notice by
5:00 p.m. ET on Monday, June 30, 2014, with their request to present
oral comments at the meeting. Interested individuals and
representatives of organizations must submit a written/electronic copy
of the oral presentation/statement including a brief description of the
organization represented by 5:00 p.m. ET on Tuesday, July 1, 2014.
Statements submitted will become a part of the public record. Only one
representative of an organization will be allowed to present oral
comments and presentations will be limited to three to five minutes per
speaker, depending on the number of speakers to be accommodated within
the allotted time. Speakers will be assigned a time to speak in the
order of the date and time when their request to speak is received,
along with the required submission of the written/electronic statement
by the specified deadline.
In addition, any interested person may submit written comments to
the IACC prior to the meeting by sending the comments to the Contact
Person listed on this notice by 5:00 p.m. ET on Tuesday, July 1, 2014.
The comments should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person. NIMH anticipates written public comments received by
5:00 p.m. ET, Tuesday, July 1, 2014 will be presented to the Committee
prior to the meeting for the Committee's consideration. Any written
comments received after the 5:00 p.m. EST, July 1, 2014 deadline
through July 7, 2014 will be provided to the Committee either before or
after the meeting, depending on the volume of comments received and the
time required to process them in accordance with privacy regulations
and other applicable Federal policies. All written public comments and
oral public comment statements received by the deadlines for both oral
and written public comments will be provided to the IACC for their
consideration and will become part of the public record.
In the 2009 IACC Strategic Plan, the IACC listed the ``Spirit of
Collaboration'' as one of its core values, stating that, ``We will
treat others with respect, listen to diverse views with open minds,
discuss submitted public comments, and foster discussions where
participants can comfortably offer opposing opinions.'' In keeping with
this core value, the IACC and the NIMH Office of Autism Research
Coordination (OARC) ask that members of the public who provide public
comments or participate in meetings of the IACC also seek to treat
others with respect and consideration in their communications and
actions, even when discussing issues of genuine concern or
disagreement.
Remote Access
The meeting will be open to the public through a conference call
phone
[[Page 32560]]
number and webcast live on the Internet. Members of the public who
participate using the conference call phone number will be able to
listen to the meeting but will not be heard. If you experience any
technical problems with the webcast or conference call, please send an
email to helpdeskiacc@gmail.com or by phone at 415-652-8023.
Individuals who participate in person or by using these electronic
services and who need special assistance, such as captioning of the
conference call or other reasonable accommodations, should submit a
request to the Contact Person listed on this notice at least 5 days
prior to the meeting.
Security
In the interest of security, visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit
upon entrance to the Neuroscience Center. Also as a part of security
procedures, attendees should be prepared to present a photo ID at the
meeting registration desk during the check-in process. Pre-registration
is recommended. Seating will be limited to the room capacity and seats
will be on a first come, first served basis, with expedited check-in
for those who are pre-registered.
Meeting schedule subject to change.
Information about the IACC is available on the Web site: https://www.iacc.hhs.gov.
Dated: May 30, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-13026 Filed 6-4-14; 8:45 am]
BILLING CODE 4140-01-P